Hercules Capital, Inc. Insider Trading

HCXY

⊜ Compare

Last 12 months

Insiders bought $2.77M on the open market and sold nothing.

Net open-market

+$2.77M

23 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

11 / 0

executives and directors

Last open-market buy

Mar 2026

Mar 26, 2026

Get an email when HCXY's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Mar 26	Deanne Aguirre Director	Bought	7,317	$14.35	105K	31%	Form 4
Mar 26	Wade Loo Director	Bought	7,317	$14.35	105K	19%	Form 4
Mar 26	Nikos Theodosopoulos Director	Bought	7,317	$14.35	105K	33%	Form 4
Mar 26	Thomas J Fallon Director	Bought	7,300	$14.30	104K	4.7%	Form 4
Mar 26	Paramjeet K Randhawa Director	Bought	2,926	$14.35	42K	15%	Form 4
Mar 26	Gayle A Crowell Director	Bought	7,317	$14.35	105K	8.1%	Form 4
Mar 26	Robert P Badavas Director	Bought	3,658	$14.35	52K	3.0%	Form 4
Mar 4	Christian Follmann Chief Operating Officer	Bought	5,000	$14.68	73K	3.2%	Form 4
Mar 4	Christian Follmann Chief Operating Officer	Bought	5,000	$14.68	73K	3.4%	Form 4
Mar 4	Paramjeet K Randhawa Director	Bought	3,050	$14.78	45K	18%	Form 4
Feb 27	Seth H Meyer Chief Financial Officer	Bought	14,000	$14.33	201K	3.2%	Form 4
Feb 27	Kiersten Zaza Botelho Chief Legal Officer & CCO	Bought	1,300	$14.21	18K	1.4%	Form 4
Feb 27	Nikos Theodosopoulos Director	Bought	2,600	$14.21	37K	14%	Form 4
Feb 27	Scott Bluestein Chief Executive Officer	Bought	7,000	$14.35	100K	0.3%	Form 4
Feb 27	Thomas J Fallon Director	Bought	20,000	$14.20	284K	15%	Form 4
Feb 27	Robert P Badavas Director	Bought	5,000	$14.27	71K	4.2%	Form 4
Feb 25	Wade Loo Director	Bought	3,300	$14.98	49K	9.1%	Form 4
Feb 24	Thomas J Fallon Director	Bought	10,000	$14.98	150K	7.9%	Form 4
Feb 24	Robert P Badavas Director	Bought	5,000	$15.01	75K	4.4%	Form 4
Feb 24	Scott Bluestein Chief Executive Officer	Bought	30,000	$15.08	452K	1.2%	Form 4
Feb 23	Gayle A Crowell Director	Bought	6,600	$15.20	100K	8.2%	Form 4
Feb 17	Nikos Theodosopoulos Director	Bought	6,165	$15.93	98K	48%	Form 4
Feb 17	Thomas J Fallon Director	Bought	20,000	$15.88	318K	19%	Form 4
Nov 3, 2025	Gayle A Crowell Director	Bought	6,000	$17.77	107K	8.3%	Form 4
Jun 5, 2025	Christian Follmann Chief Operating Officer	Bought	395	$17.83	7K	0.3%	Form 4
Jun 5, 2025	Christian Follmann Chief Operating Officer	SoldNo plan	395	$17.83	7K	0.3%	Form 4
May 8, 2025	Nikos Theodosopoulos Director	Bought	5,999	$17.49	105K	101%	Form 4
May 8, 2025	Wade Loo Director	Bought	5,999	$17.49	105K	23%	Form 4
May 8, 2025	Gayle A Crowell Director	Bought	5,999	$17.49	105K	9.5%	Form 4
May 8, 2025	Robert P Badavas Director	Bought	1,799	$17.49	31K	1.6%	Form 4
May 8, 2025	Deanne Aguirre Director	Bought	5,999	$17.49	105K	43%	Form 4
May 8, 2025	Thomas J Fallon Director	Bought	5,976	$17.53	105K	6.0%	Form 4

Mar 26
Deanne Aguirre
Director · bought 7,317 at $14.35
105K
31% of stake
Mar 26
Wade Loo
Director · bought 7,317 at $14.35
105K
19% of stake
Mar 26
Nikos Theodosopoulos
Director · bought 7,317 at $14.35
105K
33% of stake
Mar 26
Thomas J Fallon
Director · bought 7,300 at $14.30
104K
4.7% of stake
Mar 26
Paramjeet K Randhawa
Director · bought 2,926 at $14.35
42K
15% of stake
Mar 26
Gayle A Crowell
Director · bought 7,317 at $14.35
105K
8.1% of stake
Mar 26
Robert P Badavas
Director · bought 3,658 at $14.35
52K
3.0% of stake
Mar 4
Christian Follmann
Chief Operating Officer · bought 5,000 at $14.68
73K
3.2% of stake
Mar 4
Christian Follmann
Chief Operating Officer · bought 5,000 at $14.68
73K
3.4% of stake
Mar 4
Paramjeet K Randhawa
Director · bought 3,050 at $14.78
45K
18% of stake
Feb 27
Seth H Meyer
Chief Financial Officer · bought 14,000 at $14.33
201K
3.2% of stake
Feb 27
Kiersten Zaza Botelho
Chief Legal Officer & CCO · bought 1,300 at $14.21
18K
1.4% of stake
Feb 27
Nikos Theodosopoulos
Director · bought 2,600 at $14.21
37K
14% of stake
Feb 27
Scott Bluestein
Chief Executive Officer · bought 7,000 at $14.35
100K
0.3% of stake
Feb 27
Thomas J Fallon
Director · bought 20,000 at $14.20
284K
15% of stake
Feb 27
Robert P Badavas
Director · bought 5,000 at $14.27
71K
4.2% of stake
Feb 25
Wade Loo
Director · bought 3,300 at $14.98
49K
9.1% of stake
Feb 24
Thomas J Fallon
Director · bought 10,000 at $14.98
150K
7.9% of stake
Feb 24
Robert P Badavas
Director · bought 5,000 at $15.01
75K
4.4% of stake
Feb 24
Scott Bluestein
Chief Executive Officer · bought 30,000 at $15.08
452K
1.2% of stake
Feb 23
Gayle A Crowell
Director · bought 6,600 at $15.20
100K
8.2% of stake
Feb 17
Nikos Theodosopoulos
Director · bought 6,165 at $15.93
98K
48% of stake
Feb 17
Thomas J Fallon
Director · bought 20,000 at $15.88
318K
19% of stake
Nov 3, 2025
Gayle A Crowell
Director · bought 6,000 at $17.77
107K
8.3% of stake
Jun 5, 2025
Christian Follmann
Chief Operating Officer · bought 395 at $17.83
7K
0.3% of stake
Jun 5, 2025No plan
Christian Follmann
Chief Operating Officer · sold 395 at $17.83
7K
0.3% of stake
May 8, 2025
Nikos Theodosopoulos
Director · bought 5,999 at $17.49
105K
101% of stake
May 8, 2025
Wade Loo
Director · bought 5,999 at $17.49
105K
23% of stake
May 8, 2025
Gayle A Crowell
Director · bought 5,999 at $17.49
105K
9.5% of stake
May 8, 2025
Robert P Badavas
Director · bought 1,799 at $17.49
31K
1.6% of stake
May 8, 2025
Deanne Aguirre
Director · bought 5,999 at $17.49
105K
43% of stake
May 8, 2025
Thomas J Fallon
Director · bought 5,976 at $17.53
105K
6.0% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch HCXY, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Held by ETFs

HCXY is in 8 US ETFs. The largest of them, with HCXY's weight in each:

Spot a number that looks wrong? Check it in HCXY's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing HCXY

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.